Top High Tech Stocks To Watch For 2019

Small cap Tex Mex or Mexican restaurant stock El Pollo LoCo Holdings Inc (NASDAQ: LOCO) reportedQ2 2017 earnings after the market closed Thursday.

Total revenue increased 8.3% to $105.6 million as system-wide comparable restaurant sales increased 2.9% -including a 2.4% increase for company-operated restaurants and a 3.2% increase for franchised restaurants. The growth in company-operated restaurant revenue was largely driven by the 24 new restaurants opened during and subsequent to the second quarter of 2016. Comparable company-operated restaurant sales increased 2.4%, driven by a 0.5% increase in transactions and a 1.9% increase in average check. Net income was $7.8 million versus net income of $7.3 million. The CEO commented:

“During the second quarter we achieved solid results, including system-wide comparable store sales growth of 2.9% and a return to positive transaction growth. Our core business continues to perform well, driven by our strategy to highlight our authentic brand, our differentiated offerings, and our QSR+ positioning. Additionally we made progress against new technology initiatives focused on driving convenience and loyalty, rolling out delivery and launching our all-new Loco Rewards loyalty program.”

Top High Tech Stocks To Watch For 2019: Finjan Holdings, Inc.(FNJN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Finjan (NASDAQ: FNJN) and Dolby Laboratories (NYSE:DLB) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, profitability, valuation and risk.

  • [By Logan Wallace]

    The Joint (NASDAQ: JYNT) and Finjan (NASDAQ:FNJN) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership and profitability.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Finjan (FNJN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Money Morning Staff Reports]

    That’s why today we’ll show you one of our expert recommendations along with the 10 top-performing penny stocks to watch this week…

    Penny Stocks Current Share Price
    (as of Feb. 20) Feb. 12-20 Gain
    (as of Feb. 20)
    POET Technologies Inc. (OTCMKTS: POETF) $0.4165 85.1%
    Finjan Holdings Inc. (Nasdaq: FNJN) $2.94 67.05%
    Intelsat SA (NYSE: I) $3.50 38.89%
    Genesis Healthcare Inc. (NYSE: GEN) $1.39 37.62%
    Paringa Resources Ltd. (OTCMKTS: PNGZF) $0.41 32.30%
    CytoDyn Inc. (OTCMKTS: CYDY) $0.76 31.03%
    Iconix Brand Group Inc. (Nasdaq: ICON) $1.65 30.95%
    AMERI Holdings Inc. (Nasdaq: AMRH) $2.49 29.69%
    Pangea Logistics Solutions Ltd. (Nasdaq: PANL) $2.87 26.99%
    MoSys Inc. (Nasdaq: MOSY) $1.47 25.68%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

Top High Tech Stocks To Watch For 2019: Ligand Pharmaceuticals Incorporated(LGND)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Ligand Pharmaceuticals (LGND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    These are some of the news stories that may have effected Accern Sentiment’s scoring:

    Get Ligand Pharmaceuticals alerts:

    Ligand Pharmaceuticals (LGND) Insider Sells $1,488,722.03 in Stock (americanbankingnews.com) Geron (GERN) Q1 Loss Narrows Y/Y, Revenues Fall, Shares Down (finance.yahoo.com) Ligand Pharmaceuticals (LGND) Upgraded to A- by TheStreet (americanbankingnews.com) Ligand to Participate in Upcoming Investor Conferences (finance.yahoo.com) Ligand Pharmaceuticals Shows Rising Price Performance With Jump To 87 RS Rating (investors.com)

    A number of research firms recently issued reports on LGND. TheStreet raised Ligand Pharmaceuticals from a “c+” rating to an “a-” rating in a research report on Wednesday. HC Wainwright reissued a “buy” rating and set a $170.00 price objective on shares of Ligand Pharmaceuticals in a research report on Friday, February 2nd. Zacks Investment Research raised Ligand Pharmaceuticals from a “hold” rating to a “buy” rating and set a $171.00 price objective for the company in a research report on Wednesday, February 28th. BidaskClub cut Ligand Pharmaceuticals from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 27th. Finally, Roth Capital lifted their price objective on Ligand Pharmaceuticals from $158.00 to $171.00 and gave the company a “buy” rating in a research report on Monday, February 26th. One research analyst has rated the stock with a sell rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $161.00.

  • [By Logan Wallace]

    Ligand Pharmaceuticals (NASDAQ:LGND) announced its quarterly earnings results on Tuesday. The biotechnology company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.98, Bloomberg Earnings reports. The firm had revenue of $56.16 million during the quarter, compared to analysts’ expectations of $43.02 million. Ligand Pharmaceuticals had a net margin of 8.90% and a return on equity of 14.44%. The company’s revenue for the quarter was up 91.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.57 earnings per share. Ligand Pharmaceuticals updated its FY18 guidance to $4.85 EPS.

Top High Tech Stocks To Watch For 2019: Landec Corporation(LNDC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Landec (LNDC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com